Clinical Trial Update: Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a completed Phase 1/2 clinical trial evaluating the combination of pemetrexed (Alimta) and epirubicin in locally advanced or metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Epirubicin (epirubicin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED